Laser eye treatment is one of many treatment alternatives for people with vision problems. Learn more about treatment guidelines and options available today.
pSivida Corp. (NASDAQ: PSDV) (ASX: PVA), a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye diseases, including clinical stage product candidates for the treatment of diabetic macular edema (DME), uveitis aff
Drug delivery company pSivida Corp. (NASDAQ:PSDV) (ASX:PVA) today announced the opening of an investigational new drug application (IND) for a Phase I/II clinical trial to study pSividas injectable, sustained release ...
WATERTOWN, Mass.--(BUSINESS WIRE)--pSivida announces start of its own clinical trial of injectable sustained release ophthalmic insert for posterior uveitis
pSivida Corp. Posted on:12 Sep 11 Drug delivery company pSivida Corp. (NASDAQ:PSDV) (ASX:PVA) today announced the opening of an investigational new drug application (IND) for a Phase I/II clinical trial to study pSivida’s injectable, sustained rele